key: cord-0028869-nve690bz authors: Zeng, Ping; Liu, Wei; Zhang, Shumin; Du, Shaopeng; Fan, Yihua; Zhao, Longmei; Wang, Aihua title: Integrated Network Pharmacology and Mice Model to Investigate Qing Zao Fang for Treating Sjögren's Syndrome date: 2022-01-10 journal: Evid Based Complement Alternat Med DOI: 10.1155/2022/3690016 sha: 4ce0803206a23e80b7221bdfa7004958263d40e9 doc_id: 28869 cord_uid: nve690bz Sjögren's syndrome (SS) is an autoimmune disease, and its conventional treatment has exhibited limited therapeutic efficacy. Qing Zao Fang (QZF), a traditional Chinese medicine formula, is used in the treatment of Sjögren's syndrome, but its chemical composition is complex, and its pharmacological mechanism is not clear. Therefore, this study aims to explore the potential mechanism of QZF in the treatment of Sjögren's syndrome based on network pharmacology and SS mouse model. The main active components and predicted targets of QZF were analyzed by network pharmacology. The SS mouse model was constructed and divided into 6 groups: control, SS, SS + hydroxychloroquine (HCQ)-treated, SS + low-dose QZF-treated, SS + medium-dose QZF-treated, and SS + high-dose QZF-treated group. Immunohistochemical, ELISA, and qRT-PCR assays were performed to detect the expressions of targets associated with SS. TUNEL staining was used to detect apoptosis. Cumulatively, 230 active compounds and 1883 targets of QZF were identified. There were 227 common targets for QZF and SS. The effective active ingredients were stigmasterol, neocryptotanshinone II, neotanshinone C, miltionone I, and beta-pinene. It mainly acts on biological processes such as inflammatory response, chemokine metabolic process, and immune response as well as pathways such as FoxO signaling pathway, Yersinia infection, HIF-1 signaling pathway, and TNF signaling pathway. In SS mice, levels of AKT1, HIF-1α, TNF-α, IL-6, and IL-17A were increased, while decreased after QZF treatment. In contrast, IL-10 levels were decreased in SS mice and increased in QZF-treated mice. In addition, QZF reduced apoptosis in the submandibular gland tissue compared to SS mice. It can be concluded that the QZF in treatment of SS is the result of the combined action of multiple components, multiple targets, and multiple pathways. This study improves the understanding of the link between QZF and SS on molecular mechanisms. Sjögren's syndrome (SS) is well-recognized as a systemic autoimmune disease, and it is characterized by manifestations of sicca (dryness) of the oral, ocular mucosa, and genital taking diverse exocrine glands as targets [1] . is disorder is categorized into primary SS existing as an independent entity and secondary SS with a coexisting entity [2] . Symptoms of secondary SS are aggravated accompanying with additional autoimmune diseases including systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis [3] . e spread of this disorder can cause several organic extraglandular manifestations of the skin, thyroid, liver, lungs, kidneys, gastrointestinal tracts, and nervous systems as well [3, 4] . So far, studies have suggested that the incidence of SS is related to genetics, viral infection, related cytokines, neurohormone disorders, and environmental factors, yet it is still insufficiently understood, diagnosed, and treated [5] . As a chronic autoimmune disease, the pathogenesis of SS remains insufficiently identified. Numerous experiments have shown that B cells collaborate with T cells to activate in response to autoantigens in this disease, resulting in lymphocyte infiltration and immune complex deposition [6] . Results of function analysis using murine SS models have elucidated that 1, 2, and 17 cells are of great significance in the occurrence and development of SS, which play roles in regulating the differentiation, amplification, and functions of self-reactive T and B cells [7] [8] [9] . Furthermore, inflammatory cytokines balance the epithelial homeostasis and modulates the functions of B and T cells [3] . Ectopic expressions of CXC chemokines (CXCL9, CXCL10, CXCL11, and CXCL13), interleukins (IL-1/2/4/6/10/12/17/ 22/23), IFN-c, and TNF-α occur in the minor salivary glands of SS patients as compared to healthy individuals [10, 11] . Current therapeutic options for SS mainly relies on improving mouth and eye dryness and suppressing immune responses, such as artificial tears and saliva substitutes, nonsteroidal anti-inflammatory drugs, glucocorticoids, hydroxychloroquine, synthetic immunosuppressive agents, and T or B cell-targeting biological therapies [12] . Despite alleviation of those sicca symptoms, clinical treatment of SS remains a challenge: a specific therapeutic target as the most important goal is in urgent need beyond symptom relief [12] . In light of the principle of the traditional Chinese medicine (TCM), SS is classified into the "dryness arthralgia" category, and the symptoms has been demonstrated to be alleviated, guiding under the TCM pathogenesis of "deficiency, stasis, and toxicity" [13] . Some herbal formulae or single herb have been proved to play roles in reducing IFN-c and IL-4 contents in the peripheral blood and increasing the secretion of saliva of SS patients [14, 15] . Xuan-Shen (Scrophularia ningpoensis), Mai-Men-Dong (Ophiopogon japonicus), and Sheng-Di-Huang (Rehmannia glutinosa) were the widely introduced single herbs for treating SS [16] . Since the concept of network pharmacology was first proposed by Hopkins [17] as part of bioinformatics, it has been extensively applied in relevant studies of complex TCM compounds. e reason lies in the fact that network pharmacology combines system network analysis and pharmacology and simultaneously contains the connotation of holistic theory of TCM with multicomponents, multitargets, and multipathways [18] . According to the pathogenesis characteristics of SS, we composed QZF based on the theory of "deficiency, stasis, and toxicity." is study intends to systematically summarize the potential effective components and action pathways of QZF in SS treatment using analysis of network pharmacology and mouse model experiments in vivo. It is expected to provide an insight into the clinical applications using pharmacological analysis for the treatment of SS. e bioinformatic platforms BATMAN-TCM (http://bionet. ncpsb.org/batman-tcm/) and TCMSP (http://lsp.nwu.edu. cn/tcmsp.php) were utilized to obtain the active components and putative targets of QZF [19, 20] . QZF is made of 10 herbs: Mai Dong (Ophiopogon japonicus) 10 g, Shi Hu (Herba Dendrobii) 10 g, Yu Zhu (Polygonatum odoratum) 10 g, Sheng Di Huang (Rehmannia glutinosa) 10 g, and Gan Cao (Glycyrrhiza uralensis) 6 g, and so on. e scores of predicted candidate targets (including known targets) which were not smaller than the score cutoff 20 of the ingredients were presented. ID information of the active components were obtained from the PubChem (https://pubchem.ncbi. nlm.nih.gov/). We input "Sjögren's syndrome" as the keyword in the GeneCards database (https:// www.genecards.org/) to sort out SS-related targets [21] . e predicted targets of QZF and targets of SS were subsequently uploaded to the SangerBox data analysis platform (http:// sangerbox.com/) to obtain their common targets. To further investigate the potential mechanisms of QZF on SS, we constructed protein-protein interaction (PPI) network diagrams through the Search Tool for the Retrieval of Interacting Genes (STRING) database (https://string-db.org/) [22] . e CentiScaPe plugin tool of software Cytoscape 3.6.1 was applied for the calculation of degree centrality (DC) of each node, and the top 20 DC values of the core targets were chosen for further analysis. e values of "degree" represented the number of edges connected to a node and the importance representative of each node [23] . e diagram construction of the QZF compound-target network was completed using the software Cytoscape 3.6.1 [24] . Following import of the 20 core targets into Cytoscape, analysis of GO biological process and KEGG pathway enrichment were subsequently conducted by using the ClueGO plugin at an adjusted p values of <0.05 [25] . Target protein analysis was performed using the GO analysis with the entries of the top 20 functional categories from biological process (BP), cellular component (CC), molecular function (MF), and immune system process (IS). e GO and KEGG analysis results were uploaded to SangerBox for visualization. e animal experiments gained approval of the Guiyang Second Affiliated Hospital of Traditional Chinese Medicine. e spontaneous SS model in NOD mice were used for experimental study which is naturally produced under natural conditions without artificial induction or due to genetic mutation, and often represents a mouse model that has been retained through genetic breeding [26] . A total of 40 SPF female NOD mice aged 8 weeks and 8 eight-weeks-old SPF female BALB/c mice were sourced from Chongqing Tengxin Biotechnology Co., Ltd (Chongqing, China). e animals were maintained in specific pathogen-free animal houses. e SS mouse model was described by Lin et al. [9] . e blank control group used the BALB/c mice. e NOD mice were randomly divided into 5 groups (8 each): SS, SS + HCQ-treated, SS + low-dose QZF-treated, SS + medium-dose QZF-treated, and SS + high-dose QZF-treated group. QZF is the experience prescription and provided by the pharmacy of the Guiyang Second Affiliated Hospital of Traditional Chinese Medicine. It was formulated based on the basic theories of traditional Chinese medicine and clinical experience to treat Sjögren's syndrome. e toxicity and adverse effects induced by QZF were detected: there is a certain possibility of causing central obesity, elevated fasting blood sugar, insomnia, and elevated blood pressure [27] . Mice in each group were fed adaptively for 2 weeks and then given intragastric treatment. QZF in treating primary Sjögren's syndrome was studied in clinic, the dosage of QZF was determined in the previous literature, and according to the body weight of human and animal, low-dose QZF water decoction (14.5 g kg −1 /d), medium-dose (29 g kg −1 / d), and high-dose (58 g kg −1 /d) were given orally, once a day, respectively [28, 29] . e positive control group was given hydroxyl chloroquine (40 g kg −1 /d) water solution for consecutive 6 weeks, while an equal amount of normal saline (0.2 mL/d) was given to both the blank and SS model control groups by gavage. After four weeks of continuous administration, the mice were anesthetized and sacrificed using pentobarbital sodium at 50 mg/kg as per body weight. Blood samples from mice eyeballs and submandibular gland tissue were collected for subsequent experiments. e mouse submandibular gland was prepared for total RNA extraction using the TRNzol-A reagent (Tiangen, Beijing, China). e Primer Script RT Reagent Kit was employed for reverse transcription synthesis of cDNA (Beijing Kangrun Chengye Biotechnology Co., Ltd, Beijing, China) as per the manufacturer's instructions of use. qRT-PCR was carried out on an ABI 7500 instrument ( ermo Fisher Scientific, Inc.) using 2 × Taq PCRStar Mix (Beijing Kangrun Chengye Biotechnology Co., Ltd, Beijing, China). e reaction system was as follows: 95°C for 30 sec, followed by 40 cycles of 95°C for 5 sec, 55°C for 30 sec, and 72°C for 30 sec. β-actin was then utilized as an internal control and repeated 3 times for each sample. Next, we identified the expression of SS-related protein in serum using the ELISA kit based on the manufacturer's instructions. e ELISA kits of IL-1, IL-2, IL-6, IL-10, IL-17A, and IFN-c were purchased from MultiSciences (LiankeBio) Biotech Co., Ltd. (Hangzhou, China). Briefly, 100 μl sample was added to wells and incubated for 2 h at room temperature (RT). Each well was aspirated and washed five times before adding antibody (100 μl), then incubated for 1 h at RT, and aspirated and wash five times again. Working reagent (100 μl) was added, incubated for 30 min at RT, and aspirated and washed. One-step substrate reagent (100 μl), 3,3′,5,5′tetramethylbenzidine (TMB) was added and incubated for 30 min at RT. Stop solution (50 μl) was added and the absorbance was read at 450 nm within 30 min. e salivary gland tissue fixation was conducted using 4% paraformaldehyde (Solarbio, Shanghai, China) and followed by paraffin embedment to make 5 μm sections. Following deparaffinization, the sections were incubated with 3% H 2 O 2 (Sinopharm, China) for 10 min and 0.1% trypsin (Beyotime, China) for 20 min, followed by primary antibodies incubated at 4°C overnight. PBS was used for the treatment of the negative control instead of primary antibodies. en, the sections were incubated at 37°C for 30 min with HRP-conjugated secondary antibodies. Finally, the bound antibodies were stained with diaminobenzidine (DAB, Zhongshan, Beijing, China) and followed by hematoxylin (Jiancheng, Nanjing, China) counterstaining of the sections. An inverted microscope (Olympus, Japan) was employed for image acquisition. e primary antibodies anti-IL-6, anti-IL-10, and anti-IL-17 were purchased from Abcam. e submandibular gland tissue was initially extracted and cell lysis buffer (Beyotime Biotechnology, Jiangsu, China) was used to add 1 mM phenylmethanesulfonyl fluoride (Beyotime Biotechnology, Jiangsu, China) to extract protein lysates. e cell membrane and cytoplasm was obtained by cell disruption. e protein samples of different molecular weights were separated by 10% SDS/PAGE and transferred into polyvinylidene difluoride membranes (Millipore, Billerica, MA). en, the samples were washed with TBST and blocked with phosphate-buffered saline (PBS) containing 5% blotting-grade blocker for 1 h. Followed by blocking, three times washing, each for 5 min, was performed with tris-buffered saline with Tween 20 (TBST). e appropriate primary antibody (1 : 1000) incubation was performed on the transferred membrane at 4°C overnight and then followed by 1 h IgG (1 : 2000, ABclonal) incubation at room temperature. Proteins bands were visualized with ultrasensitive chemiluminescence kits (10300, New Cell & Molecular Biotech Co, Ltd, Suzhou, China). e catalogue number and brand of used primary antibodies were listed as follows: anti-Bcl-2 (#2876, Cell Signaling Technology), anti-Bax (#2772, Cell Signaling Technology), and β-actin (ab8227, Abcam). Also, anti-IL-6, anti-IL-10, and anti-IL-17 were purchased from Abcam. Following three cycles of washing with PBS, the sections of salivary gland tissue cells were stained using TUNEL kits [cat. no. 11684817910; Roche Diagnostics (Shanghai) Co., Ltd.] as per the manufacturer's instructions of use. Observation of apoptotic cells was performed under an inverted fluorescence microscope (cat. no. CKX53; Olympus Corporation) at magnification ×400 folds. Samples in four fields were randomly calculated, and brown color represented the apoptotic cells, and blue, the nucleus pulposus. 2.9. Statistical Analysis. Data obtained from the previously described procedures were presented as mean ± standard deviation. All experiments were independently duplicated Evidence-Based Complementary and Alternative Medicine three times. Statistical analyses of the data were performed using the SPSS 23.0 software (IBM Corp.). One-way analysis of variance (ANOVA) was employed for comparison among multiple groups followed by Tukey's post hoc test. p < 0.05 denoted that the difference was statistically significant. Screening of active components and targets of QZF were conducted using the platforms of BATMAN-TCM and TCMSP, and 230 active components and 1883 predictive targets were obtained. rough GeneCards retrieval, 1038 SS target genes were collected, and the corresponding targets of each component of QZF were intersected with targets of SS. ere were 227 common targets between the QZF and SS (Figure 1(a) ). PPI network graphs of 227 common targets were obtained using the String website ( Figure 1(b) ). e degree centrality (DC) value of PPI was calculated by the software Cytoscape 3.6.1. to screen out the 20 targets with the largest DC value, among which IL-6, INS, GAPDH, AKT1, and TNF may be the most core targets of QZF in the treatment of SS because of the highest DC value (Figure 1(c) ). e compound-target network of QZF was established (Figure 1(d) ). Only 9 herbs and 59 active components corresponded to the 20 common targets. Among the active compounds 5280794 (stigmasterol), 15690458 (neocryptotanshinone II), 5320114 (neotanshinone C), 5319835 (miltionone I), and 14896 (betapinene) had the highest DC values. Taken together, the compounds presenting the highest relative positioning DC values were considered as the potential key active compounds. To verify whether QZF in treating SS produced any biological responses, we performed GO analysis on the 20 SS-related potential therapeutic target genes on the processes of BP, CC, IS, and MF. After filtering by adjusted p value < 0.05, 20 GO terms were displayed. In BP enrichment analysis, most terms are related with inflammatory response, gene silencing, and chemokine metabolic process (Figure 2(a) ). CC was not shown in this article because only one term was related. In IS enrichment analysis, CD4-positive T cell cytokine production, T-helper 17 cell differentiation, and T-helper 17 type immune response presented the highest gene ratio value (Figure 2(b) ). In MF enrichment analysis, terms were related with positive regulation of NF-κB transcription factor activity, nitric oxide synthase activity, and oxidoreductase activity (Figure 2(c) ). ese targets were enriched in 56 pathways, and the adjusted p value was less than 0.05. e KEGG enrichment analysis of the top 20 entries is shown in Figure 2 Most of the cytokines that target SS contain the TNF family, IFN family, IL-1, IL-2, IL-6, IL-10, and IL-17 [3] . Hydroxychloroquine is the main medicine for the treatment of SS patients. To detect whether QZF have protective effects against SS, the SS mice model was established. In combination with the published literature and pharmacological analysis, the SS-related gene was measured by qRT-PCR. Results showed that AKT1, HIF-1α, IL-6, IL-17A, and TNF-α levels was markedly elevated in the serum of SS mice compared to those of the control. eir levels were significantly downregulated in the QZF-or HCQ-treated group compared with those of the SS model group, while IL-10 levels significantly decreased in serum from SS mice and upregulated in the QZF-or HCQ-treated SS mice. Besides, this effect did not show significant dosedependence (Figure 3(a) ). SS-related proteins were determined using ELISA and immunohistochemistry. e ELISA results indicated that levels of IL-17A and IL-6 were downregulated in the QZFtreated group in comparison to those of the SS model group whereas the IL-10 level was elevated in the QZF-treated group. IL-1, IL-2, and INF-c showed no significant difference between the SS model group and the QZF-treated group. is may be because that the SS is a systemic autoimmune disease which mainly involves exocrine invasion, more significant inflammation may be observed in the exocrine glands (Figure 3(b) ). At the same time, the specific mechanism of IL-1, IL-2, and INF-c in SS has been studied in some research works [30] , and the current clinical treatment of SS is more focused on IL-17 [31] ; therefore, we concentrate more on IL-17 and research on HIF-1α. In the light of the above results, we detected the levels of IL-6, IL-10, and IL-17A in the submandibular gland tissue of mice by immunohistochemistry, which was consistent with the ELISA assay (Figure 4(a) ). Furthermore, the IL-6, IL-10, and IL-17A protein expression in the submandibular gland tissue was detected by WB as well. e results showed the QZF can significantly decrease the IL-6 and IL-17A expression and promote the expression of IL-10 compared with that of SS (Figures 4(b)-4(e) ). Tissue. We further examined whether QZF could affect the apoptosis of submandibular gland tissue. Apoptosis was measured by using the TUNEL assay and Bcl-2/Bax ratio in the submandibular gland tissue of mice that were treated or not with QZF. Bax gene is a proapoptotic member of the Bcl-2 family, and dimerization among members is an important form of functional regulation. Bax and Bcl-2 heterodimer can inhibit Bcl-2 and play a role in promoting cell apoptosis. As shown in Figure 5(a) , the TUNEL-positive cells were observed in the SS group, and high-dose QZF can decrease the positive cells. e Bcl-2/Bax ratio was significantly increased in QZF-treated mice compared with SS mice, and the apoptosis was inhibited (Figures 5(b) and 5(c) ). e 4 Evidence-Based Complementary and Alternative Medicine results suggested that apoptosis of the submandibular gland tissue of SS mice was substantially increased, while it was greatly decreased after QZF or HCQ treatment ( Figure 5 ). is implied that QZF has a positive effect on SS mice. TCM has named the SS as either "dry-Bi" or "dryness impediment." Our preliminary studies have demonstrated that most SS patients present features of Qi and Yin deficiency including manifestation of blood stasis [14] . Some clinical trials have confirmed that SS treatment using TCM combined with Western medicine exerts a favorable effect on the disease, allowing to nourish Yin, supplement Qi, and activate blood circulation [14] . In accordance with this theory, we formulated QZF (Mai Dong, Shi Hu, Yu Zhu, Sheng Di Huang, Gan Cao, and so on) which could nourish Yin and moisten dryness. e top 3 single herbs for SS treatment in Taiwan are known as Xuan Shen (Scrophularia ningpoensis), Mai Dong, and Sheng Di Huang [16] . However, the underlying molecular mechanisms which drive the SS pathogenesis have not been fully elucidated, and genetic factors, viral infections, immune system exceptions, inflammatory infiltration, neural hormones, and IL4 ICAM1 IGF1 EGFR MAPK8 CCL2 STAT3 EGF MMP9 IL1B IL10 TLR4 TP53 TNF AKT1 GAPDH INS IL6 20 Evidence-Based Complementary and Alternative Medicine environmental factors are considered to be the important factors that cause the disease [32] . Due to the complexity of this disease, its treatment has always been a difficult point in research. Not a recognized specific drug has been available in treating SS in the market, and most of them adopt symptomatic treatment, but all of them have problems such as uncertain efficacy and large toxic side effects [12] . erefore, a novel and potent therapy for SS treatment is in urgent need from a broader perspective. e extensive application of "compound-proteins" pathways have become the TCM network pharmacology research hotspot, allowing to vividly interpreting the complicated interactions of biological systems, drugs, and diseases [33] . Because of these characteristics, network pharmacology has Evidence-Based Complementary and Alternative Medicine been considered the next paradigm in drug discovery. In this study, network pharmacology was used to analyze the active components of QZF in the treatment of SS and to predict its therapeutic target and pathway, so as to provide theoretical support for its clinical effectiveness. In the early stages of SS, CD4+ T cells, B cells, CD8+ T cells, macrophages, and dendritic cells are the infiltrating cells in lacrimal and salivary glands, and among these cells, CD4+ T cells are the most common [34] . 17 cells, a subset of CD4+ memory effector T cells, secrete IL-17A and IL-17F under the stimulation of TGF-β and IL-6 stimulation [35] . It was noted that increased IL-17 levels were found in minor salivary glands of SS patients, and the expression of IL-17 is correlated with the severity of inflammation [36] . No disease development was observed in IL-17 knockout mice, and mice models of SS showed the strongest evidence of IL-17 and 17 in SS disease [37] . IL-6, IFN-c, and IL-1 levels are also increased in serum, saliva, and tears of SS patients [38] . IL-10 has a rather anti-inflammatory or protective action toward glandular injury in SS [11] . Furthermore, a statistically significant overall decrease in mean IL-10 levels occurs, while IL-6 and TNF-α levelssignificantly increased in pSS patients [39] . Results of in vivo showed that IL-6, IL-17A, and TNF-α were upregulated in serum and submandibular gland of SS mice, and IL-10 was downregulated, which was consistent with previous research. In SS mice treated with QZF, levels of IL-6, IL-17A, and TNF-α were reduced while IL-10 levels increased. GO analysis of the QZF-therapeutic potential target genes also showed that CD4-positive T cell cytokine production, 17 cell differentiation, and 17 type immune response were important GO terms. TNF, IL-6, IL-1B, and IL-10 are the top four targets in KEGG analysis. However, our results showed no significant difference in IFN-c and IL-1 in QZF-treated SS mice. ese results suggest that QZF maybe regulate the expression of TNF-α, IL-17A, IL-6, and IL-10 to treat SS. KEGG analysis showed that the related pathways of QZF in the treatment of SS included the FOXO signaling pathway, Yersinia infection, TNF signaling pathway, and HIF-1 signaling pathway. ere are 20 pathways, which are closely related to inflammatory response, oxidative stress, autophagy, apoptosis, and submandibular gland cell signaling. A large number of experimental studies have shown that the FOXO family of transcription factors plays a crucial role in many basic cellular processes such as immune regulation, metabolism, proliferation, apoptosis, and oxidative stress response [40] [41] [42] . Inhibition of FOXO1 can reduce the expression of TNF-α and IL-6 [43] . Moreover, pSS patients had significantly higher levels of the proinflammatory cytokines IL-17, IL-6, and TNF-α along with a significant decrease in the anti-inflammatory cytokine IL-10 and FOXP3 mRNA expression compared with healthy controls [39] . Many studies have shown that hypoxia-inducible factor-1 (HIF-1) pathway is involved in the pathogenesis of autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and SS [44] [45] [46] [47] . Inhibition of HIF-1α can prevent local capillary hyperplasia and reduce CD4+T differentiation to 17 cells, thereby reducing inflammatory response and reducing apoptosis of exocrine glands such as lacrimal salivary glands and salivary glands [45] . Akt is one of the important components of PI3K/Akt pathway, which is closely related to cell survival, apoptosis, and other biological activities [48] . Phosphorylated Akt can enhance the activity of HIF-1α, thereby initiating the transcription of HIF-1αrelated target genes and ultimately enhancing cell proliferation and inhibiting cell apoptosis [49] . ese findings suggest that HIF-1 is closely related to the PI-3K/Akt signaling pathway, which has potential research value in the treatment of immune diseases. In addition, it has been reported that HIF-1 can affect the ratio of 17 and Treg cells and then cause the immune imbalance of 17 and Treg cells [50] . In this study, levels of Akt and HIF-1α and apoptotic rate were significantly decreased in QZF-treated SS mice. It is implied that QZF may regulate apoptosis of the submandibular gland tissue through these pathways, thus slowing down SS. In this work, we proposed a network pharmacology approach, combining SS mice model to explore the efficiency of QZF for the treatment of SS. To sum up, our results suggested that the QZF might mainly regulated inflammatory response, chemokine metabolic process, immune system, and cell apoptosis by the FOXO signaling pathway, TNF signaling pathway, and HIF-1 signaling pathway to play an important role in the treatment of SS. Akt1, HIF-1α, TNF-α, IL-17A, IL-6, and IL-10 may be the key target gene of QZF in the treatment of SS. Stigmasterol, neocryptotanshinone II, neotanshinone C, miltionone I, and beta-pinene may be the important active ingredients of QZF in the treatment of SS. ese results demonstrated that QZF had the characteristics of multicomponent, multitarget, and multipathway therapy for SS, providing potential drugs and targets for the treatment of SS. Data Availability e data supporting the findings of this study are available from the corresponding author upon request. e authors declare no conflicts of interest. Ping Zeng and Wei Liu are co-first author. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome Neuro-sjögren: uncommon or underestimated problem? Innate immunity and biological therapies for the treatment of Sjögren's syndrome Sjögren's syndrome: diagnosis and management Update on pathogenesis of Sjogren's syndrome A potential of sFasL in preventing gland injury in Sjogren's syndrome T cell-associated cytokines in the pathogenesis of Sjögren's syndrome Proteasome inhibition suppresses 17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome 17 cells play a critical role in the development of experimental Sjögren's syndrome Transcriptomic and network analysis of minor salivary glands of patients with primary Sjögren's syndrome Modulation of apoptosis by cytotoxic mediators and cellsurvival molecules in Sjögren's syndrome EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies Chinese herbal medicine SS-1 inhibits T cell activation and abrogates TH responses in Sjögren's syndrome Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the 1/ 2 immune balance in peripheral blood in patients with primary Sjogren's syndrome Effectiveness of traditional Chinese medicine compound JieDuTongLuoShengJin granules treatment in primary sjögren's syndrome: a randomized, double-blind, placebo-controlled clinical trial e core pattern analysis on Chinese herbal medicine for Sjögren's syndrome: a nationwide population-based study Network pharmacology: the next paradigm in drug discovery Network pharmacology in research of Chinese medicine formula: methodology, application and prospective BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine Deciphering the molecular targets and mechanisms of HGWD in the treatment of rheumatoid arthritis via network pharmacology and molecular docking Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19 STRING v10: protein-protein interaction networks, integrated over the tree of life Cooperation and interplay between base and nucleotide excision repair pathways: from DNA lesions to 14 Evidence-Based Complementary and Alternative Medicine proteins Cytoscape: software for visualization and analysis of biological networks Assessing the pharmacological and therapeutic efficacy of traditional Chinese medicine liangxue tongyu prescription for intracerebral hemorrhagic stroke in neurological disease models Spontaneous model of Sjogren's syndrome in NOD mice Clinical observation on qing Zao Fang in treating Sjögren's syndrome Clinical observation on ziyin qingzaofang in treating primary Sjögren's syndrome A simple practice guide for dose conversion between animals and human NOD mouse model for Sjögren's syndrome: lack of longitudinal stability Blocking IL-17: a promising strategy in the treatment of systemic rheumatic diseases Advances in mast cell activation by IL-1 and IL-33 in Sjögren's syndrome: promising inhibitory effect of IL-37 Network pharmacology databases for traditional Chinese medicine: review and assessment Unique phenotypes and functions of follicular helper T cells and regulatory T cells in sjögren's syndrome e IL-17 family of cytokines in health and disease Helper 17 cells in primary Sjögren's syndrome Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome Cathepsin S alters the expression of proinflammatory cytokines and MMP-9, partially through protease-activated receptor-2, in human corneal epithelial cells Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary sjögren's syndrome Simvastatin inhibits CYR61 expression in orbital fibroblasts in graves' ophthalmopathy through the regulation of FoxO3a signaling FOXO3 is targeted by miR-223-3p and promotes osteogenic differentiation of bone marrow mesenchymal stem cells by enhancing autophagy Foxo1-mediated inflammatory response after cerebral hemorrhage in rats Mucosal immunity and the FOXO1 transcription factors Hypoxia-inducible factor-1α and autoimmune Activation of HIF-1α (hypoxia inducible factor-1α) prevents dry eye-induced acinar cell death in the lacrimal gland HIF1A (rs11549465) and AKNA (rs10817595) gene polymorphisms are associated with primary Sjögren's syndrome HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus Resveratrol inhibits IL-1β-mediated nucleus pulposus cell apoptosis through regulating the PI3K/Akt pathway Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway Smoking under hypoxic conditions: a potent environmental risk factor for inflammatory and autoimmune diseases